Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:32755584  

Sialyl-LewisX Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy.

Florent Colomb | Leila B Giron | Leticia Kuri-Cervantes | Opeyemi S Adeniji | Tongcui Ma | Harsh Dweep | Emilie Battivelli | Eric Verdin | Clovis S Palmer | Hiroaki Tateno | Andrew V Kossenkov | Nadia R Roan | Michael R Betts | Mohamed Abdel-Mohsen
Cell reports | 2020

A comprehensive understanding of the phenotype of persistent HIV-infected cells, transcriptionally active and/or transcriptionally inactive, is imperative for developing a cure. The relevance of cell-surface glycosylation to HIV persistence has never been explored. We characterize the relationship between cell-surface glycomic signatures and persistent HIV transcription in vivo. We find that the cell surface of CD4+ T cells actively transcribing HIV, despite suppressive therapy, harbors high levels of fucosylated carbohydrate ligands, including the cell extravasation mediator Sialyl-LewisX (SLeX), compared with HIV-infected transcriptionally inactive cells. These high levels of SLeX are induced by HIV transcription in vitro and are maintained after therapy in vivo. Cells with high-SLeX are enriched with markers associated with HIV susceptibility, signaling pathways that drive HIV transcription, and pathways involved in leukocyte extravasation. We describe a glycomic feature of HIV-infected transcriptionally active cells that not only differentiates them from their transcriptionally inactive counterparts but also may affect their trafficking abilities.

Pubmed ID: 32755584

Antibodies used in this publication

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: R21 NS106970
  • Agency: NIA NIH HHS, United States
    Id: R01 AG062383
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK123733
  • Agency: NIAID NIH HHS, United States
    Id: R21 AI143385
  • Agency: NIAID NIH HHS, United States
    Id: R21 AI129636
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS117458
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI131374

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Novus Biologicals (tool)

RRID:SCR_004286

Commercial antibody vendor which supplies antibodies and other products to life science researchers.

View all literature mentions

Cell Signaling Technology (tool)

RRID:SCR_004431

Privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study cell signaling pathways that impact human health.

View all literature mentions

PRISM (tool)

RRID:SCR_005375

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.

View all literature mentions

NCBI Epigenomics (tool)

RRID:SCR_006151

THIS RESOURCE IS NO LONGER IN SERVICE, documented on January 19, 2022.

View all literature mentions

PeproTech (tool)

RRID:SCR_006802

An Antibody supplier

View all literature mentions

QIAGEN (tool)

RRID:SCR_008539

A commercial organization which provides assay technologies to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

View all literature mentions

Miltenyi Biotec (tool)

RRID:SCR_008984

An Organization portal, Antibody supplier, Service resource,

View all literature mentions

Sigma-Aldrich (tool)

RRID:SCR_008988

American chemical, life science and biotechnology company owned by Merck KGaA. Merger of Sigma Chemical Company and Aldrich Chemical Company. Provides organic and inorganic chemicals, building blocks, reagents, advanced materials and stable isotopes for chemical synthesis, medicinal chemistry and materials science, antibiotics, buffers, carbohydrates, enzymes, forensic tools, hematology and histology, nucleotides, proteins, peptides, amino acids and their derivatives.

View all literature mentions

BD Biosciences (tool)

RRID:SCR_013311

An Antibody supplier

View all literature mentions

New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions

Agilent Technologies (tool)

RRID:SCR_013575

Company provides laboratories worldwide with analytical instruments and supplies, clinical and diagnostic testing services, consumables, applications and expertise in life sciences and applied chemical markets.

View all literature mentions

NIH AIDS Reagent Program (tool)

RRID:SCR_023191

NIH HIV Reagent Program has been managed under contract by American Type Culture Collection (ATCC) since 2020. ATCC shall maintain the NIH HIV Reagent Program through identification, acquisition, production, receipt, storage, maintenance, distribution and disposal of biological and chemical research organisms and materials for HIV and other infectious diseases for use in basic and translational research.

View all literature mentions

ACH-2 (tool)

RRID:CVCL_0138

Cell line ACH-2 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

U-118MG (tool)

RRID:CVCL_0633

Cell line U-118MG is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

WI (tool)

RRID:RGD_13508588

Rattus norvegicus with name WI from RGD.

View all literature mentions

HLA-DR (antibody)

RRID:AB_2744478

This monoclonal targets HLA-DR

View all literature mentions

CD194 (CCR4) (antibody)

RRID:AB_2739215

This monoclonal targets CD194 (CCR4)

View all literature mentions

CD8 (antibody)

RRID:AB_2744460

This monoclonal targets CD8

View all literature mentions

Anti-Human CD62L (DREG-56)-153Eu (antibody)

RRID:AB_2810245

This monoclonal targets CD62L/L-selectin

View all literature mentions

CD195 (CCR5) (antibody)

RRID:AB_2739037

This monoclonal targets CD195 (CCR5)

View all literature mentions

CD3 (antibody)

RRID:AB_2739277

This monoclonal targets CD3

View all literature mentions

CD196 (antibody)

RRID:AB_11154229

This monoclonal targets CD196 (CCR6)

View all literature mentions

CD4 (antibody)

RRID:AB_2744421

This monoclonal targets CD4

View all literature mentions

CD185 (CXCR5) (antibody)

RRID:AB_2738871

This monoclonal targets CD185 (CXCR5)

View all literature mentions

CD45RA (antibody)

RRID:AB_2744407

This monoclonal targets CD45RA

View all literature mentions

CD38 (antibody)

RRID:AB_2744377

This monoclonal targets CD38

View all literature mentions

Ki-67 (antibody)

RRID:AB_2738577

This monoclonal targets Ki-67

View all literature mentions

CD25 (IL-2 Receptor α) (antibody)

RRID:AB_2744342

This monoclonal targets CD25 (IL-2 Receptor α)

View all literature mentions

Anti-Human CD27-167Er (antibody)

RRID:AB_2811093

This monoclonal targets CD27

View all literature mentions

Anti-Human CD3-170Er (antibody)

RRID:AB_2811085

This monoclonal targets CD3

View all literature mentions

CD15s (Sialyl Lewis x) (antibody)

RRID:AB_2738258

This monoclonal targets CD15s (Sialyl Lewis x)

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

RStudio (software resource)

RRID:SCR_000432

Open source and enterprise ready professional software for R statistical computing environment. Integrated development environment for R. Includes console, syntax highlighting editor that supports direct code execution, as well as tools for plotting, history, debugging and workspace management. Available in open source and commercial editions and runs on desktop Windows, Mac, and Linux or in browser connected to RStudio Server or RStudio Server Pro (Debian/Ubuntu, RedHat/CentOS, and SUSE Linux).

View all literature mentions

FlowJo (software resource)

RRID:SCR_008520

Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.

View all literature mentions

DESeq2 (software resource)

RRID:SCR_015687

Software package for differential gene expression analysis based on the negative binomial distribution. Used for analyzing RNA-seq data for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates.

View all literature mentions

RSEM (software resource)

RRID:SCR_013027

Software package for quantifying gene and isoform abundances from single end or paired end RNA Seq data. Accurate transcript quantification from RNA Seq data with or without reference genome. Used for accurate quantification of gene and isoform expression from RNA-Seq data.

View all literature mentions

Ingenuity Pathway Analysis (pathway analysis tool)

RRID:SCR_008653

A web-based software application that enables users to analyze, integrate, and understand data derived from gene expression, microRNA, and SNP microarrays, metabolomics, proteomics, and RNA-Seq experiments, and small-scale experiments that generate gene and chemical lists. Users can search for targeted information on genes, proteins, chemicals, and drugs, and build interactive models of experimental systems. IPA allows exploration of molecular, chemical, gene, protein and miRNA interactions, creation of custom molecular pathways, and the ability to view and modify metabolic, signaling, and toxicological canonical pathways. In addition to the networks and pathways that can be created, IPA can provide multiple layering of additional information, such as drugs, disease genes, expression data, cellular functions and processes, or a researchers own genes or chemicals of interest.

View all literature mentions

BD FACSDiva Software (software resource)

RRID:SCR_001456

A collection of tools for flow cytometer and application setup, data acquisition, and data analysis that help streamline flow cytometry workflows. It provides features to help users integrate flow systems into new application areas, including index sorting for stem cell and single-cell applications, as well as automation protocols for high-throughput and robotic laboratories.

View all literature mentions

Bowtie (software resource)

RRID:SCR_005476

Software ultrafast memory efficient tool for aligning sequencing reads. Bowtie is short read aligner.

View all literature mentions